Dr. Reddy's Biosimilar Tie With Merck Serono Leads Firm's Europe Effort
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories it betting on a tie up with German drug maker Merck Serono to develop biosimilars of cancer drugs, including Roche's Rituxan (rituximab) in Europe in the next four years.